FEATURES OF BRAIN NEUROTROPHIC FACTOR BDNF AND CORTISOL LEVELS IN PATIENTS WITH VARIOUS FORMS OF EPILEPSY
Keywords:
epilepsy, focal epilepsy, generalised epilepsy, BDNF, cortisol, neuroplasticity, neuroendocrine regulationAbstract
Epilepsy is accompanied by impaired neuroplasticity and dysregulation of the hypothalamic-pituitary-adrenal (HAP) axis. BDNF and cortisol are considered potential biomarkers of disease severity and forms, but data on their ratio in various forms of epilepsy are contradictory.
References
Binder D.K., Scharfman H.E. Brain-derived neurotrophic factor // Growth Factors. 2004. Vol. 22. P. 123–131.
Binder D.K., Croll S.D., Gall C.M., Scharfman H.E. BDNF and epilepsy: Too much of a good thing? // Trends in Neurosciences. 2001. Vol. 24. P. 47–53.
Scharfman H.E. Brain-derived neurotrophic factor and epilepsy // Progress in Brain Research. 2004. Vol. 146. P. 93–100.
Murray K.D., Isackson P.J., Eskin T.A., et al. Altered expression of brain-derived neurotrophic factor and TrkB receptors in epileptic hippocampus // Journal of Neuroscience. 2000. Vol. 20. P. 7570–7579.
Simonato M., Tongiorgi E., Kokaia M. Angels and demons: Neurotrophic factors and epilepsy // Trends in Pharmacological Sciences. 2006. Vol. 27. P. 631–638.
Kanner A.M. Psychiatric and cognitive comorbidities in epilepsy: Current concepts and future directions // Epilepsy & Behavior. 2021. Vol. 121. Article 108052.
Mula M. Cognitive dysfunction in epilepsy: A contemporary review // Epilepsy & Behavior. 2021. Vol. 121. Article 108045.
